Bottom line
ECHSX vs XLV: the short answer
ECHSX (Eaton Vance Worldwide Health Sciences Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.
XLV is cheaper at 0.08% vs 1.93% — a difference of $185 a year per $10,000 invested.
Over five years, XLV returned +8.1% a year vs +5.6% for ECHSX (reporting dates differ).
Updated Nov 19, 2026
ECHSX vs XLV side by side
| ECHSX | XLV | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Morgan Stanley | SPDR (State Street) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.93% | 0.08% |
| Annual cost per $10k | $193 | $8 |
| 10-yr cost on $10k (prospectus) | $2,089 | $103 |
| Max front load | 0% | None |
| 12b-1 fee | 1% | 0.02% |
| 1-yr return | +1.7% | +14.5% |
| 5-yr return (annualized) | +5.6% | +8.1% |
| 10-yr return (annualized) | +6.3% | +9.8% |
| Best quarter | — | +14.5% |
| Worst quarter | — | −12.7% |
| Net assets (fund) | $757.9M | $40.6B |
| Number of holdings | 42 | 65 |
| Portfolio turnover | 3% | 2% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
14 of ECHSX's top 25 holdings also appear in XLV's top 25.
| Holding | ECHSX | XLV |
|---|---|---|
| Eli Lilly & Co | 12.47% | 16.51% |
| AbbVie Inc | 6.46% | 7.74% |
| Johnson & Johnson | 6.45% | 10.64% |
| UnitedHealth Group Inc | 5.49% | 6.57% |
| Merck & Co Inc | 5.08% | 5.52% |
| Bristol-Myers Squibb Co | 4.25% | 2.05% |
| Vertex Pharmaceuticals Inc | 3.38% | 2.19% |
| Gilead Sciences Inc | 3.34% | 2.73% |
| Thermo Fisher Scientific Inc | 2.79% | 3.24% |
| Intuitive Surgical Inc | 2.72% | 2.45% |
| Stryker Corp | 2.21% | 1.89% |
| Boston Scientific Corp | 2.18% | 1.10% |
| Medtronic PLC | 1.80% | 1.75% |
| Abbott Laboratories | 1.65% | 2.75% |
Source: SEC Form N-PORT
ECHSX top 10
- Eli Lilly & Co — 12.47%
- AbbVie Inc — 6.46%
- Johnson & Johnson — 6.45%
- AstraZeneca PLC — 6.24%
- UnitedHealth Group Inc — 5.49%
- Roche Holding AG — 5.44%
- Merck & Co Inc — 5.08%
- Bristol-Myers Squibb Co — 4.25%
- Vertex Pharmaceuticals Inc — 3.38%
- Gilead Sciences Inc — 3.34%
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
FAQ
What is the difference between ECHSX and XLV?
ECHSX (Eaton Vance Worldwide Health Sciences Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds. XLV is cheaper at 0.08% vs 1.93% — a difference of $185 a year per $10,000 invested.
Which is cheaper, ECHSX or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both ECHSX and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.